Skip to main content
PolicySpeak
← All files
IDF

International Diabetes Federation Europe

NGO · Belgium · EU Transparency Register 80267287489-88

5
positions filed
in the 665 files tracked
4
legislative files
of 665 tracked
3
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1106 non-governmental organisations on this site, they rank #308 by legislative files engaged, a count of participation, not a measure of influence.

7.8
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
6
EP accreditations
as declared to the register
2011
in the register since

Declares membership of

  • IDF Europe is member of:
  • EPHA - European Public Health Alliance
  • EPF - European Patients Forum
  • ESWI - European Scientific Working group on Influenza
  • EMA - European Medicines Agency
  • ECDA - European Chronic Disease Alliance
  • EU Platform for action on diet, physical activity and health
  • EU Platform on Mental Health and Covid-19
  • EU Health Coalition
  • EU Health Policy Forum
  • EASD - European Association for the Study of Diabetes (Attendance to EASD General Assembly), transnational member of IDF
  • SFD - Société Francophone du Diabète, transnational member of IDF
  • and 1 more

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).

Register category
Non-governmental organisations
Registered as
International Diabetes Federation European Region (IDF Europe)
Head office
Brussels, Belgium

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track International in PolicySpeak: request access →

Follow International Diabetes Federation Europe

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at International Diabetes Federation Europe? so we know who speaks for it.

Their record over time

International Diabetes Federation Europe filed 5 positions between 27 Apr 2021 and 28 Jul 2026, across 4 of the 665 legislative files tracked here, attaching a full position paper 3 times.

2021 · 1 filed2022 · 1 filed2025 · 1 filed2026 · 2 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 8 Jun 2026PDFsource

IDF Europe represents 72 national diabetes associations across 45 countries in the European Region. IDF Europe acknowledges the importance of the Medical Devices Regulation in ensuring the quality, safety and performance of medical devices that are placed on the EU market.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025source

Medical devices have become an essential component of diabetes management. Yet, despite their increasing availability, many of the 34 million people living with diabetes in the EU do not achieve their treatment targets. This highlights the need to foster more innovation and facilitate the introduction of new devices that better meet people's needs.

Medicinal products for human usefiled 27 Apr 2021PDFsource

IDFE, a pan-European organisation representing people living with diabetes (PwD) and healthcare professionals (HCPs) in 70 member associations across 44 countries in Europe, welcomes the opportunity to respond to the evaluation and revision of the general pharmaceutical legislation.

European Biotech Actfiled 28 Jul 2026source

For the 34 million people living with diabetes in the EU, biotechnology has the potential to transform prevention, treatment and long-term care. Advances such as next-generation insulins, cell and gene-based therapies and other biotechnology-derived medicines could significantly improve health outcomes and quality of life. Europe already has the scientific excellence to lead this transformation.

European Health Data Spacefiled 28 Jul 2022PDFsource

IDF Europe, representing both people living with diabetes (PwD) and healthcare professionals (HCPs) through a network of 70 national diabetes associations across Europe, strongly welcomes the Commission’s European Health Data Space (EHDS) proposal, which we believe, could make a meaningful difference to the health and well-being of the 32 million adults (one in 10) living with diabetes in the European Union (EU) as…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put International Diabetes Federation Europe next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 135.

Is this your organization?

Everything on this page comes from International Diabetes Federation Europe’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.